ORKA — ORUKA THERAPEUTICS INC

Ownership history in VR Adviser, LLC  ·  6 quarters on record

This page tracks every 13F SEC filing in which VR Adviser, LLC reported a position in ORUKA THERAPEUTICS INC (ORKA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
6.21% (2025 Q4)
Avg. % of fund
4.36%
First filed
2024 Q3
Last filed
2025 Q4
Quarters held
6
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 4,148,428 — 0% 6.21% $125.7M $30.31
2025 Q3 UNCHANGED 4,148,428 — 0% 4.49% $79.8M $19.23
2025 Q2 UNCHANGED 4,148,428 — 0% 3.48% $46.5M $11.21
2025 Q1 ADDED 4,148,428 +862,808 +26.3% 3.62% $42.6M $10.26
2024 Q4 ADDED 3,285,620 +200,000 +6.5% 4.37% $63.7M $19.39
2024 Q3 INITIATED 3,085,620 — — 3.96% $75.6M $24.51
% of Fund (quarterly)    ORKA price (monthly, adj. close)

Other funds also holding ORKA

As of 2025 Q4 — sorted by position size

Remedium Capital Partners, LLC 27.64% Fairmount Funds Management LLC 3Y 8.55% Avidity Partners Management LP 3Y 5.77% Commodore Capital LP 3Y 3.54% SR ONE CAPITAL MANAGEMENT, LP 3Y 1.85% GREAT POINT PARTNERS LLC 3Y 7Y 1.8% B Group, Inc. 1.68% Synergy Asset Management, LLC 3Y 1.45% Affinity Asset Advisors, LLC 3Y 1.39% Paradigm Biocapital Advisors LP 3Y 1.32%
← Back to VR Adviser, LLC Holdings